Cite
HARVARD Citation
Huo, S. et al. (n.d.). Capture of common adverse events (AEs) by patient-reported outcome measures (PROMs) used in clinical trials of immuno-oncology (IO)-based combination therapies in advanced renal cell carcinoma (aRCC).. Journal of clinical oncology. 40 (28), p. 263. [Online].